Vildan Avkan Oguz (Vildan Avkan Oğuz, Vildan Avkan-Oguz, Vildan Avkan-Oğuz)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Journal of neurology

Infectious diseases & clinical microbiology

Irish journal of medical science

Turkish journal of medical sciences

Dokuz Eylul Universitesi Tip Fakultesi

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dokuz Eylul Universitesi Tip Fakultesi

Turkey

Prof, MD :: Infectious Diseases and Clinical Microbiology

Publications

Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology 271 (7) (2024)
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology (2024)
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology 271 (7) (2024)
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology 271 (7) (2024)
Muammer Çelik, Cavid Baba, Çağlar Irmak, Serkan Özakbaş, Vildan Avkan Oguz
Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey. Journal of neurology 271 (7) (2024)
Ahmet Naci Emecen, Salih Keskin, Oyku Turunc, Ahmet Furkan Suner, Neslisah Siyve, Ecem Basoglu Sensoy, Fatih Dinc, Oğuz Kılınç, Vildan Avkan Oguz, Serdar Bayrak, Belgin Ünal
The presence of symptoms within 6 months after COVID-19: a single-center longitudinal study. Irish journal of medical science (2022)
Vildan Avkan Oguz, Çağlar Irmak, Kağan Dağdeviren, Oya Özlem Eren Kutsoylu, Nazlı Arzu, Muammer Çelik, Serdar Bayrak
The Effect of the Pandemic on Antifungal Use: What Has Changed? Infectious diseases & clinical microbiology 4 (3) (2022)
Oya Özlem Eren Kutsoylu, Ozgur Appak, Nazlı Arzu, Gokcen Omeroglu-Simsek, Nil Tekin, Başak Bayram, Ayca Arzu Sayiner, Nesim Tanglay, Vildan Avkan Oguz
Evaluation of SARS-CoV-2 antibody persistence and viral spread in stool: a long-term care experience before COVID-19 vaccination. Irish journal of medical science (2022)
Vildan Avkan Oguz, Çağlar Irmak, Kağan Dağdeviren, Oya Özlem Eren Kutsoylu, Nazlı Arzu, Muammer Çelik, Serdar Bayrak
The Effect of the Pandemic on Antifungal Use: What Has Changed? Infectious diseases & clinical microbiology 4 (3) (2022)
Nur Yapar, Eyüp Sabri Uçan, Firat Bayraktar, Necati Ali Gökmen, Arzu Sayıner, Ziya Kuruüzüm, Başak Bayram, Sema Alp-Çavuş, Oğuz Kılınç, Vildan Avkan Oguz, Yusuf Savran, Semih Küçükgüçlü, Murat Celiloğlu
COVID-19 Pandemic Action Plan of a University Hospital. Turkish thoracic journal 22 (1) (2021)
Aylin Özgen Alpaydın, Mücahit Özbilgin, Madina Abdulleyeva, Selver Seda Mersin, Tufan Egeli, Tarkan Unek, Oğuz Kılınç, İbrahim Kemal Astarcıoğlu, Vildan Avkan Oguz
Determinants and characteristics of tuberculosis in liver transplant recipients Turkish journal of medical sciences 48 (6) (2018)

Vildan Avkan Oguz.css-eqlu8i{font-size:small;padding-left:4px;} (Vildan Avkan Oğuz, Vildan Avkan-Oguz, Vildan Avkan-Oğuz)

Publication Activity (10 Years)

Top Topics

Top Venues

Vildan Avkan Oguz (Vildan Avkan Oğuz, Vildan Avkan-Oguz, Vildan Avkan-Oğuz)